Development of biodegradable starch microspheres for intranasal delivery

Indian Journal of Pharmaceutical Sciences

Volumn 70, Issue 2, 2008, Pages 170-174

  Yadav, A ^a   Mote, H ^a  

^a Government College of Pharmacy   (India)

Author keywords

Bioadhesive; Crosslinking; Domperidone; Microspheres; Mucoadhesion; Nasal drug delivery; Starch

Indexed keywords

DOMPERIDONE; EPICHLOROHYDRIN; STARCH MICROSPHERE;

ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; EMULSION; ENCAPSULATION; NONHUMAN; NOSE MUCOSA; PARTICLE SIZE;

EID: 46349094433     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.41450     Document Type: Article

References (20)

1. Illum LJ. Nasal drug delivery-possibilities, problems and solution. J Control Release 2003;87:187-98.
2. Aurora J. Development of nasal delivery system: A review. Drug Deliv Technol 2002;2(7):70-3.
3. Turker S, Anur E, Ozer Y. Nasal route and drug delivery system. Pharm World Sci 2004;26:137-42.
4. Dondeti P, Zia H, Needham TE. Bioadhesive and formulation parameters affecting nasal absorption. Int J Pharm 1996;127:115-33.
5. Wade A, Weller PJ. A Handbook of pharmaceutical excipients, A joint publication of the American Pharma. Association and the Pharma. Great Britain: Society of Great Britain; 1994. p. 289-95.
6. Lllum L, Jorgensen J, Bisgaord H, Krogsgaard O, Rossing N. Bioadhesive microspheres as a potential nasal drug delivery system. Int J Pharm 1987;39:189-99.
7. Mao S, Chen J, Wei Z, Liv H, Bi D. Intranasal administration of melatonin starch microspheres. Int J Pharm 2004;272:37-43.
8. Reynolds JEF. Martindale; The Extra pharmacopoeia. 30th ed. Royal Society Of Great Britain. London: The Pharmaceutical Press; 1999.
9. Krymchantowski YA. Acute treatment of migraine: Breaking the paradigm of monotherapy. BMC Neurol 2004;44:4-5.
10. Tripathi KD. Essentials of medical pharmacology, 4th ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2001. p. 649-50.
11. Hamdi G, Pnchel G, Dunchene D. An original method for studying in vitro the enzymatic degradation of cross-linked starch microsphere. J Control Release 1998;55:193-201.
12. Capan Y, Jiang G, Giovagnali S, Na KH, Deluca PP. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of human growth harmon. AAPS Pharm Sci Tech 2003;4:1-10.
13. Parikh RH, Parikh JR, Dubey RR, Soni HN, Kapadia KN. Poly(D,L-Lactide-Co- Glycolide) microspheres containing 5-fluorouracil: Optimization of process parameters. AAPS Pharm Sci Tech 2003;4:1-8.
14. Dubey RR, Parikh RH. Two stage optimization process for formulation of chitosan microsphere. AAPS Pharm Sci Tech 2004; 5:1-9.
15. Hamdi G, Ponchel G, Enzymatic degradation of epichlorohydrine cross-linked starch microspheres by α-amylase. Pharm Res 1999;16:867-75.
16. Matazovi SA, Smart JD, An in vitro method for assessing the duration of mucoadhesion. J Control Release 1994;31:207-12.
17. Dhawan S, Singla AK, Sinha VR, Evaluation of mucoadhesive properties of chitosan microspheres prepared by different method. AAPS Pharm Sci Tech 2004;5:1-7.
18. Pisal S, Shelke V, Mahadik K, Kadam S. Effect of organogels component on in vitro nasal delivery of propanolol hydrochloride. AAPS Pharm Sci Tech 2004;4:1-9.
19. Sankar C, Mishra B. Development and in vitro evaluation of ketorolac tromethomine for intranasal administration. Acta Pharm 2003;53:101-10.
20. Hascicek C, Gonul N, Ekr N. Mucoadhesive microspheres containing gentamycin sulphate for nasal administration. Farmaco 2003;58:11-6.